La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Synthetic DNA minor groove-binding drugs

Identifieur interne : 003642 ( Main/Exploration ); précédent : 003641; suivant : 003643

Synthetic DNA minor groove-binding drugs

Auteurs : B. S. Praveen Reddy [Canada] ; S. Murari Sondhi [Inde] ; J. William Lown [Canada]

Source :

RBID : ISTEX:E2129DB6AAFCE51B6EC9A980A99B9C1A4F850F20

Abstract

In this review, both cationic and neutral synthetic ligands that bind in the minor groove of DNA are discussed. Certain bis-distamycins and related lexitropsins show activities against human immunodeficiency virus (HIV)-1 and HIV-2 at low nanomolar concentrations. DAPI binds strongly to AT-containing polymers and is located in the minor groove of DNA. DAPI intercalates in DNA sequences that do not contain at least three consecutive AT bp. Berenil can also exhibit intercalative, as well as minor groove binding, properties depending on sequence. Furan-containing analogues of berenil play an important role in their activities against Pneumocystis carinii and Cryptosporidium parvuam infections in vivo. Pt(II)-berenil conjugates show a good activity profile against HL60 and U-937 human leukemic cells. Pt-pentamidine shows higher antiproliferative activity against small cell lung, non-small cell lung, and melanoma cancer cell lines compared with many other tumor cell lines. trans-Butenamidine shows good anti-P. carinii activity in rats. Pentamidine is used against P. carinii pneumonia in individuals infected with HIV who are at high risk from this infection. A comparison of the cytotoxic potencies of adozelesin, bizelesin, carzelesin, cisplatin, and doxorubicin indicates that adozelesin is a potent analog of CC-1065. Naturally occurring pyrrolo[2,1-c][1,4]benzodiazepines such as anthramycin have a 2- to 3-bp sequence specificity, but a synthetic PBD dimer spans 6 bp, actively recognizing a central 5′-GATC sequence. The crosslinking efficiency of PBD dimers is much greater than that of other major groove crosslinkers, such as cisplatin, melphalan, etc. Neothramycin is used clinically for the treatment of superficial carcinoma of the bladder.

Url:
DOI: 10.1016/S0163-7258(99)00021-2


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Synthetic DNA minor groove-binding drugs</title>
<author>
<name sortKey="Reddy, B S Praveen" sort="Reddy, B S Praveen" uniqKey="Reddy B" first="B. S. Praveen" last="Reddy">B. S. Praveen Reddy</name>
</author>
<author>
<name sortKey="Sondhi, S Murari" sort="Sondhi, S Murari" uniqKey="Sondhi S" first="S. Murari" last="Sondhi">S. Murari Sondhi</name>
</author>
<author>
<name sortKey="Lown, J William" sort="Lown, J William" uniqKey="Lown J" first="J. William" last="Lown">J. William Lown</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E2129DB6AAFCE51B6EC9A980A99B9C1A4F850F20</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1016/S0163-7258(99)00021-2</idno>
<idno type="url">https://api-v5.istex.fr/document/E2129DB6AAFCE51B6EC9A980A99B9C1A4F850F20/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002472</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002472</idno>
<idno type="wicri:Area/Istex/Curation">002472</idno>
<idno type="wicri:Area/Istex/Checkpoint">001281</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001281</idno>
<idno type="wicri:doubleKey">0163-7258:1999:Reddy B:synthetic:dna:minor</idno>
<idno type="wicri:Area/Main/Merge">003C21</idno>
<idno type="wicri:Area/Main/Curation">003642</idno>
<idno type="wicri:Area/Main/Exploration">003642</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Synthetic DNA minor groove-binding drugs</title>
<author>
<name sortKey="Reddy, B S Praveen" sort="Reddy, B S Praveen" uniqKey="Reddy B" first="B. S. Praveen" last="Reddy">B. S. Praveen Reddy</name>
<affiliation wicri:level="1">
<country>Canada</country>
<wicri:regionArea>Department of Chemistry, University of Alberta, Edmonton, AB</wicri:regionArea>
<wicri:noRegion>AB</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sondhi, S Murari" sort="Sondhi, S Murari" uniqKey="Sondhi S" first="S. Murari" last="Sondhi">S. Murari Sondhi</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Chemistry, University of Roorkee, Roorkee - 247667 (U.P.)</wicri:regionArea>
<wicri:noRegion>Roorkee - 247667 (U.P.)</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lown, J William" sort="Lown, J William" uniqKey="Lown J" first="J. William" last="Lown">J. William Lown</name>
<affiliation wicri:level="1">
<country wicri:rule="url">Canada</country>
</affiliation>
<affiliation wicri:level="1">
<country>Canada</country>
<wicri:regionArea>Department of Chemistry, University of Alberta, Edmonton, AB</wicri:regionArea>
<wicri:noRegion>AB</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Pharmacology and Therapeutics</title>
<title level="j" type="abbrev">JPT</title>
<idno type="ISSN">0163-7258</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1999">1999</date>
<biblScope unit="volume">84</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="1">1</biblScope>
<biblScope unit="page" to="111">111</biblScope>
</imprint>
<idno type="ISSN">0163-7258</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0163-7258</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In this review, both cationic and neutral synthetic ligands that bind in the minor groove of DNA are discussed. Certain bis-distamycins and related lexitropsins show activities against human immunodeficiency virus (HIV)-1 and HIV-2 at low nanomolar concentrations. DAPI binds strongly to AT-containing polymers and is located in the minor groove of DNA. DAPI intercalates in DNA sequences that do not contain at least three consecutive AT bp. Berenil can also exhibit intercalative, as well as minor groove binding, properties depending on sequence. Furan-containing analogues of berenil play an important role in their activities against Pneumocystis carinii and Cryptosporidium parvuam infections in vivo. Pt(II)-berenil conjugates show a good activity profile against HL60 and U-937 human leukemic cells. Pt-pentamidine shows higher antiproliferative activity against small cell lung, non-small cell lung, and melanoma cancer cell lines compared with many other tumor cell lines. trans-Butenamidine shows good anti-P. carinii activity in rats. Pentamidine is used against P. carinii pneumonia in individuals infected with HIV who are at high risk from this infection. A comparison of the cytotoxic potencies of adozelesin, bizelesin, carzelesin, cisplatin, and doxorubicin indicates that adozelesin is a potent analog of CC-1065. Naturally occurring pyrrolo[2,1-c][1,4]benzodiazepines such as anthramycin have a 2- to 3-bp sequence specificity, but a synthetic PBD dimer spans 6 bp, actively recognizing a central 5′-GATC sequence. The crosslinking efficiency of PBD dimers is much greater than that of other major groove crosslinkers, such as cisplatin, melphalan, etc. Neothramycin is used clinically for the treatment of superficial carcinoma of the bladder.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>Inde</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Reddy, B S Praveen" sort="Reddy, B S Praveen" uniqKey="Reddy B" first="B. S. Praveen" last="Reddy">B. S. Praveen Reddy</name>
</noRegion>
<name sortKey="Lown, J William" sort="Lown, J William" uniqKey="Lown J" first="J. William" last="Lown">J. William Lown</name>
<name sortKey="Lown, J William" sort="Lown, J William" uniqKey="Lown J" first="J. William" last="Lown">J. William Lown</name>
</country>
<country name="Inde">
<noRegion>
<name sortKey="Sondhi, S Murari" sort="Sondhi, S Murari" uniqKey="Sondhi S" first="S. Murari" last="Sondhi">S. Murari Sondhi</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003642 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003642 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:E2129DB6AAFCE51B6EC9A980A99B9C1A4F850F20
   |texte=   Synthetic DNA minor groove-binding drugs
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022